# Azurity Pharmaceuticals, Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/azurity-pharmaceuticals-inc/be6c2042-21df-4e44-a30d-11c6629303d8

> Inspection records and compliance data for Azurity Pharmaceuticals, Inc. in Wilmington, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Azurity Pharmaceuticals, Inc.
- FEI Number: 3003395329
- City: Wilmington
- State: Massachusetts
- Country Name: United States
- Address Line 1: 841 Woburn St
- Zip Code: 01887

## Related Documents

- [FDA Inspection 1297348 - Azurity Pharmaceuticals, Inc. - 2025-12-12](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/624df1ea-7a53-4a00-8c3c-afb7e077a0e8) — source: FDA, date: December 12, 2025
- [FDA Inspection 1297348 - Azurity Pharmaceuticals, Inc. - 2025-12-12](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/7c93bd99-060c-47b1-906c-ce6cdfe7bf52) — classification: No Action Indicated (NAI), source: FDA, date: December 12, 2025
- [483 - Azurity Pharmaceuticals, Inc. - 2025-02-19](https://www.globalkeysolutions.net/records/483/azurity-pharmaceuticals-inc/fbd8eaca-fe0a-415e-8722-8c80ddd8f442) — source: FDA, date: February 19, 2025
- [FDA Inspection 1261303 - Azurity Pharmaceuticals, Inc. - 2025-02-19](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/5bc3e1cb-551b-4b19-8657-c5a1e0e2c087) — source: FDA, date: February 19, 2025
- [483 - Azurity Pharmaceuticals, Inc. - 2023-03-02](https://www.globalkeysolutions.net/records/483/azurity-pharmaceuticals-inc/3a26f0be-61a2-41f0-9deb-51eead2d9a04) — source: FDA, date: March 2, 2023
- [483 - Azurity Pharmaceuticals, Inc. - 2022-02-24](https://www.globalkeysolutions.net/records/483/azurity-pharmaceuticals-inc/2704437d-fff0-4d09-b5aa-59c63a5d39d3) — source: FDA, date: February 24, 2022
- [FDA Inspection 1163010 - Azurity Pharmaceuticals, Inc. - 2022-02-24](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/12a62341-3a2c-4ccd-af8a-ac1ef6bbb9ad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2022
- [483 - Azurity Pharmaceuticals, Inc. - 2020-01-15](https://www.globalkeysolutions.net/records/483/azurity-pharmaceuticals-inc/5112db17-449d-4ac7-802d-0dd69b3bd25b) — source: FDA, date: January 15, 2020
- [FDA Inspection 1100022 - Azurity Pharmaceuticals, Inc. - 2019-07-26](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/824bff13-d825-4069-b07d-12705e842fb0) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2019
- [FDA Inspection 970690 - Azurity Pharmaceuticals, Inc. - 2016-04-19](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/406cc9d4-18de-434c-8f96-b6a0e230e396) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2016
- [FDA Inspection 970690 - Azurity Pharmaceuticals, Inc. - 2016-04-19](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/d7596e4b-a5e0-4350-8e79-09c75eb1d79a) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2016
- [FDA Inspection 970690 - Azurity Pharmaceuticals, Inc. - 2016-04-19](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/5756e04c-0ea5-484f-8186-33c970bbf441) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2016
- [FDA Inspection 865746 - Azurity Pharmaceuticals, Inc. - 2014-01-29](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/c7e3a821-6edb-412a-9b64-4239d82e6a03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2014
- [FDA Inspection 865746 - Azurity Pharmaceuticals, Inc. - 2014-01-29](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/ddf3c586-cea3-4b42-a9a0-2c62a45dff9b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2014

## Related Companies

- [Transdermal Cap Inc.](https://www.globalkeysolutions.net/companies/transdermal-cap-inc/04de6863-f166-4f39-af50-2e3af20c851d)
- [National Advanced Endoscopy Devices Inc](https://www.globalkeysolutions.net/companies/national-advanced-endoscopy-devices-inc/06acc5d3-a599-4eab-8af9-7f21f65bb4ea)
- [Tiller MIND BODY, Inc.](https://www.globalkeysolutions.net/companies/tiller-mind-body-inc/e447cbc4-0f73-4c3b-9330-d65ae1fb0f94)
- [Memorial Hospital For Cancer & Allied Diseases](https://www.globalkeysolutions.net/companies/memorial-hospital-for-cancer-allied-diseases/52f00fc8-a958-4fce-b4bf-07f18baf51a2)
- [Spinal Resources, Inc.](https://www.globalkeysolutions.net/companies/spinal-resources-inc/a6bc95f7-63ca-4ce6-bc11-784efa83bada)
- [Texas Tech University Health Sciences Center Center for Fertility and Reproductive Surgery](https://www.globalkeysolutions.net/companies/texas-tech-university-health-sciences-center-center-for-fertility-and-reproductive-surgery/c3990bbe-e4cf-46ac-a835-b68148d72cd3)
- [Mannkind Corporation](https://www.globalkeysolutions.net/companies/mannkind-corporation/c4fe67e8-1e0c-48fb-9847-e8a284409d8c)
- [Donald J Garcia, Jr. M.D.](https://www.globalkeysolutions.net/companies/donald-j-garcia-jr-md/a9185c7c-8af7-4f76-83f6-d313765a3dae)
- [Nestle Purina Pet Care Co.](https://www.globalkeysolutions.net/companies/nestle-purina-pet-care-co/3761fd9c-f9c7-4946-abfa-ffb31c4ad494)
- [DimcoGray Inc.](https://www.globalkeysolutions.net/companies/dimcogray-inc/9ea4c42d-f2c7-429f-aad2-3259ae7e1d00)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Investigator](https://www.globalkeysolutions.net/people/terry-bridgewater/59dfea35-4435-47b1-ac4a-0eb6eaf83bc8)
- [Robert J. Martin](https://www.globalkeysolutions.net/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)